Joseph Thome

Stock Analyst at TD Cowen

(0.41)
# 4,130
Out of 4,967 analysts
17
Total ratings
28.57%
Success rate
-20.16%
Average return

Stocks Rated by Joseph Thome

Bright Minds Biosciences
May 13, 2025
Initiates: Buy
Price Target: n/a
Current: $38.74
Upside: -
Viridian Therapeutics
Nov 25, 2024
Initiates: Buy
Price Target: n/a
Current: $18.91
Upside: -
United Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $350$400
Current: $409.71
Upside: -2.37%
Rapport Therapeutics
Jul 2, 2024
Initiates: Buy
Price Target: n/a
Current: $15.80
Upside: -
Alkermes
Jun 17, 2024
Initiates: Buy
Price Target: $34
Current: $29.53
Upside: +15.14%
Prime Medicine
Apr 8, 2024
Initiates: Buy
Price Target: n/a
Current: $3.15
Upside: -
Metagenomi
Mar 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.80
Upside: -
PTC Therapeutics
Mar 1, 2024
Maintains: Market Perform
Price Target: $32$30
Current: $52.90
Upside: -43.29%
Y-mAbs Therapeutics
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $8.57
Upside: -
Xenon Pharmaceuticals
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $39.34
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.34
Upside: -
Maintains: Outperform
Price Target: $120$130
Current: $123.10
Upside: +5.61%
Initiates: Outperform
Price Target: n/a
Current: $11.39
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $5.44
Upside: -